For the study, researchers with the Boston University School of Public Health examined the association between HDHP enrollment and access to care by race and ethnicity among cancer survivors.
The study authors used data from the National Health Interview Survey to examine this association, with 3,713 cancer survivors represented in the data. In one example, they found Black cancer survivors with an HDHP were more likely to skip medication to save money than white cancer survivors with HDHPs (22.8 percent versus 8 percent, respectively).
“This study found that the magnitude of association between HDHPs and cost-related barriers to care is larger among black cancer survivors relative to their white counterparts, elucidating the potential for HDHPs to widen documented racial/ethnic disparities in cancer outcomes.”
Read the full study here.
More articles on payers:
10 top Medicare Advantage plans, ranked by members
CVS to open Aetna office, hire 500
Blue Shield of California launches 20 pilot projects, including settling claims in real time
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.